Title of Collaborative Activity: |
NIH Recombinant DNA Advisory Committee (RAC) |
Description of Collaborative Activity: |
The Recombinant DNA Advisory Committee (RAC) advises the National Institutes of Health on the safe and ethical conduct of basic and clinical research involving recombinant or synthetic nucleic acid molecules. The Committee reviews and provides recommendations for exceptional human gene transfer protocols to enhance scientific and ethical design. The RAC also provides biosafety guidance for emerging technologies or agents. This year RAC members participated in a meeting to consider the biosafety oversight framework, and whether certain emerging technologies and other areas of life science research may raise scientific, safety, and ethical concerns that should be included in such a system. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
1974 |
NIH Participating Institutes/Centers/Office of the Director: |
NCI, NHGRI, NIAID, NINDS, OD/OSP |
HHS Agency Collaborators on this Activity: |
CDC, FDA, OS |
